Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 688 Cr.
- Current Price ₹ 23.0
- High / Low ₹ 32.8 / 18.3
- Stock P/E 13.2
- Book Value ₹ 16.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 63.0 days to 45.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Part of BSE Fast Moving Consumer Goods
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | |
| 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | |
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 |
| OPM % | 6% | 4% | 4% | 6% | 7% | 8% | 9% | 8% |
| 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | |
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 |
| Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% | 24% |
| 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | |
| EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | 1.74 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 7% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 53% |
| 3 Years: | 6% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 15% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 | |
| 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 | |
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 | |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 30 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 | |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 | |
| -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 | |
| 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 | |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -137 | -248 |
| CFO/OP | -67% | -81% | 29% | 22% | -52% | -118% | -114% | -84% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working Capital Days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
| ROCE % | 15% | 9% | 18% | 24% | 19% | 12% | 12% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Fish Meal Export Volume MT |
|
|||||||
| Fish Oil Export Volume MT |
||||||||
| Aggregate Installed Capacity - Fish Meal MTPA |
||||||||
| BSF Larvae Harvested MT |
||||||||
| Fish Meal Sales Volume MT |
||||||||
| Fish Oil Sales Volume MT |
||||||||
| Manufacturing Capacity Utilization (India Facilities) % |
||||||||
| Inventory Holding Period Days |
||||||||
| Market Share in Indian Fish Meal & Fish Oil Industry (by Revenue) % |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
10h - CARE downgraded Mukka Proteins' ₹495 crore bank facilities to BBB-/A3 with negative outlook.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
22 May - Intimation of Investor Presentation - Q4 & FY 26.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 May - FY26 revenue rose 44% to ₹1,449.5 crore; EBITDA ₹145.3 crore, PAT ₹57.1 crore; Oman, Sri Lanka expansion.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 May
-
Announcement under Regulation 30 (LODR)-Acquisition
15 May - Board approved incorporation of MPL FC HRC JV in Bangalore; company to contribute Rs. 2.55 lakh for 51% stake.
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries